(Q42627361)

4 November 2017

Synergistic effect of posaconazole and caspofungin against clinical zygomycetes (English)

1 reference

4 November 2017

5

1 reference

4 November 2017

María Guembe

1

1 reference

4 November 2017

Jesús Guinea

series ordinal

2

1 reference

4 November 2017

Teresa Peláez

series ordinal

3

1 reference

4 November 2017

Marta Torres-Narbona

series ordinal

4

1 reference

4 November 2017

language of work or name

English

0 references

publication date

18 June 2007

1 reference

Antimicrobial Agents and Chemotherapy

4 November 2017

1 reference

4 November 2017

51

1 reference

4 November 2017

9

1 reference

4 November 2017

3457-3458

1 reference

In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest

4 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043197

Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043197

In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043197

Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043197

Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043197

Combination treatment of invasive fungal infections

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043197

Eradication of Invasive Mucormycosis--Effectiveness of the Echinocandin FK463

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043197

In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043197

Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043197

Synergy, antagonism, and what the chequerboard puts between them

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17576835

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00595-07

1 reference

4 November 2017

1 reference

4 November 2017

PubMed publication ID

17576835

1 reference